Vaccines: correlates of vaccine-induced immunity
- PMID: 18558875
- DOI: 10.1086/589862
Vaccines: correlates of vaccine-induced immunity
Abstract
The immune system is redundant, and B and T cells collaborate. However, almost all current vaccines work through induction of antibodies in serum or on mucosa that block infection or interfere with microbial invasion of the bloodstream. To protect, antibodies must be functional in the sense of neutralization or opsonophagocytosis. Correlates of protection after vaccination are sometimes absolute quantities but often are relative, such that most infections are prevented at a particular level of response but some will occur above that level because of a large challenge dose or deficient host factors. There may be >1 correlate of protection for a disease, which we term "cocorrelates." Either effector or central memory may correlate with protection. Cell-mediated immunity also may operate as a correlate or cocorrelate of protection against disease, rather than against infection. In situations where the true correlate of protection is unknown or difficult to measure, surrogate tests (usually antibody measurements) must suffice as predictors of protection by vaccines. Examples of each circumstance are given.
Similar articles
-
Antibody regulation of Tcell immunity: implications for vaccine strategies against intracellular pathogens.Expert Rev Vaccines. 2004 Feb;3(1):23-34. doi: 10.1586/14760584.3.1.23. Expert Rev Vaccines. 2004. PMID: 14761241 Review.
-
A framework for assessing immunological correlates of protection in vaccine trials.J Infect Dis. 2007 Nov 1;196(9):1304-12. doi: 10.1086/522428. Epub 2007 Oct 2. J Infect Dis. 2007. PMID: 17922394
-
On immunity against infections and vaccines: credo 2004.Scand J Immunol. 2004 Jul-Aug;60(1-2):9-13. doi: 10.1111/j.0300-9475.2004.01460.x. Scand J Immunol. 2004. PMID: 15238068 Review.
-
Booster vaccinations: can immunologic memory outpace disease pathogenesis?Pediatrics. 2009 Dec;124(6):1633-41. doi: 10.1542/peds.2008-3645. Epub 2009 Nov 23. Pediatrics. 2009. PMID: 19933727 Review.
-
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know.Nat Med. 2004 Aug;10(8):806-10. doi: 10.1038/nm0804-806. Nat Med. 2004. PMID: 15286782 Review.
Cited by
-
Characterization of anti-HIV-1 neutralizing and binding antibodies in chronic HIV-1 subtype C infection.Virology. 2012 Nov 25;433(2):410-20. doi: 10.1016/j.virol.2012.08.033. Epub 2012 Sep 18. Virology. 2012. PMID: 22995189 Free PMC article.
-
What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?J Virol. 2015 Jun;89(11):5981-95. doi: 10.1128/JVI.00320-15. Epub 2015 Mar 25. J Virol. 2015. PMID: 25810537 Free PMC article.
-
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.PLoS Pathog. 2012;8(5):e1002721. doi: 10.1371/journal.ppat.1002721. Epub 2012 May 31. PLoS Pathog. 2012. PMID: 22693447 Free PMC article.
-
Immunogenicity and safety of the Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine co-administered with human rotavirus, hepatitis A and 13-valent pneumococcal conjugate vaccines: results from a phase III, randomized, multicenter study in infants.Hum Vaccin Immunother. 2019;15(2):327-338. doi: 10.1080/21645515.2018.1526586. Epub 2018 Oct 5. Hum Vaccin Immunother. 2019. PMID: 30252603 Free PMC article. Clinical Trial.
-
Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.Infect Immun. 2011 Jan;79(1):246-57. doi: 10.1128/IAI.00626-10. Epub 2010 Oct 18. Infect Immun. 2011. PMID: 20956570 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical